Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Sorafenib and Bortezomib Treatment for Relapsed or Refractory Multiple Myeloma Patients

SCRI Development Innovations, LLC · 2007
ClinicalTrials.gov · Datasets · License: Public Domain · 2007
Open Source ↗
multiple-myeloma
multiple myeloma, relapsed, refractory, sorafenib, bortezomib, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 882420
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.